Lv5
930 积分 2021-05-13 加入
Camrelizumab versus investigator's choice of chemotherapy as second-line therapy for advanced or metastatic oesophageal squamous cell carcinoma (ESCORT): a multicentre, randomised, open-label, phase 3 study
7天前
已完结
Randomized Trial of Short-Course Radiotherapy Versus Long-Course Chemoradiation Comparing Rates of Local Recurrence in Patients With T3 Rectal Cancer: Trans-Tasman Radiation Oncology Group Trial 01.04
2个月前
已完结
TGF-β builds a dual immune barrier in colorectal cancer by impairing T cell recruitment and instructing immunosuppressive SPP1+ macrophages
3个月前
已完结
Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial
3个月前
已完结
KEYNOTE-585 Fails While Matterhorn Succeeds in Gastric Cancer: What Lessons Can We Learn?
4个月前
已完结
Perioperative Durvalumab in Gastric and Gastroesophageal Junction Cancer
4个月前
已完结
Dissecting the Prediagnostic Journey to Identify Opportunities for Early Detection of Esophageal Cancer: Findings From a High-Risk Area in Rural China
4个月前
已完结
Disparities in stage at diagnosis for five common cancers in China: a multicentre, hospital-based, observational study
4个月前
已完结
Community prevention and standardized clinical treatment jointly improve cancer outcome: Real-world evidence from an esophageal cancer patient cohort study
4个月前
已完结
Analysis of the incidence and mortality trends of esophageal cancer in cancer registry areas of China and Japan
4个月前
已完结
皖公网安备34019202002308
